Penwest Pharmaceuticals Co. (PPCO) is in the Pharma Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• Penwest Pharmaceuticals Co. Q2 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator instructions Your first question is from Ian Sanderson with Cowen & Company. Ian Sanderson – Cowen & Company Good morning. Thanks for taking the question. First, and I’m not sure if you can answer this, but I’ll give it a shot, any update you...

  Earnings calls 2008-09-05

  Tags: Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Co. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line Bert Hazlett. Bert Hazlett - BMO Capital Markets Thanks for taking the question, good morning everybody. Could you just maybe elucidate a little bit better the status of the Opana ER discussions in Europe? And then could you...

  Earnings calls 2008-05-30

  Tags: Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Co. Q4 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. And your first question comes from the line of Jeff Goater with Cowen & Company. Jeff Goater – Cowen & Company Hi, good morning, thanks for taking my question. Ben, I know, you’re not providing financial guidance but can you give us a sense...

  Earnings calls 2008-04-17

  Tags: Penwest Pharmaceuticals Co.

• Endo and Penwest Receive New Paragraph IV Certification Notice From IMPAX for OPANA(R) ER

  Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) and Penwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that on December 14, 2007, they received a notice from IMPAX Laboratories, Inc. advising of the FDA's acceptance for substantive review, as of November 23, 2007, of IMPAX's Abbreviated New Drug Application ANDA containing a...

  Research articles 2007-12-17

  Tags: FDA, Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Q3 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Jeff Goater with Cowen & Company. Jeff Goater - Cowen & Company Thanks for taking the questions. Ben, just on the Otsuka arrangement in terms of the revenues that you guys booked during the quarter, is that...

  Earnings calls 2007-11-02

  Tags: Penwest Pharmaceuticals Co.

• Penwest looks to Danbury for temporary corporate home.(Penwest Pharmaceuticals considers former Union Carbide Corp. headquarters)

  The former Union Carbide headquarters in Danbury may soon be the temporary corporate headquarters of Penwest Pharmaceuticals, according to Jennifer Good, Penwest chief financial officer. Research and development staff will stay in Penwest's current l The former Union Carbide headquarters in Danbury may soon be the...

  Research articles 2002-11-25

  Tags: Penwest Pharmaceuticals Co.

• Penwest, Ranbaxy in pact. (Business - In Brief).(Nifedipine XL blood pressure prep)(Brief Article)

  Penwest Pharmaceuticals Company has granted Ranbaxy Laboratories Ltd. exclusive marketing rights in select markets for the hypertension drug ... Penwest Pharmaceuticals Company has granted Ranbaxy Laboratories Ltd. exclusive marketing rights in select markets for the hypertension drug Nifedipine XL, a controlled release version...

  Research articles 2002-03-04

  Tags: blood pressure, Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Co. (Supplier Briefs).(development joint venture with Martin Bauer Group)(Brief Article)

  Penwest Pharmaceuticals Co., Patterson, N.Y. has said its Prosolv technology will be used ... Penwest Pharmaceuticals Co., Patterson, N.Y. has said its Prosolv technology will be used in a new line of herbal supplement formulations to be co-developed by the Martin Bauer Group.

  Research articles 2002-02-01

  Tags: Penwest Pharmaceuticals Co., supplier

Additional Resources

• BeaconEquity.com Issues Trade Alerts on Market Movers: WEL, LGND, PPCO, KIDS, GNLK, VCSY

  DALLAS, Aug. 4 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's Trade Alerts include: Boots & Coots International Well Control Inc. , Ligand Pharmaceuticals...

  Articles 2008-08-04

• IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana® ER

  HAYWARD, Calif. -- IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc. ("Endo") and Penwest Pharmaceuticals, Co. ("Penwest") have filed suit for patent infringement based on the Company's amendment to its existing Abbreviated New Drug Application ("ANDA") for oxymorphone hydrochloride extended-release tablets CII, generic of Opana[R] ER, adding new 7.5 mg,...

  Articles 2008-07-28

• Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer

  EWING, N.J. -- Antares Pharma, Inc. (AMEX:AIS) announced that Paul K. Wotton, Ph.D., has joined Antares Pharma as President and Chief Operating Officer. Dr. Wotton has over 20 years experience in the pharmaceutical industry with both large and specialty pharma companies. Previously, Dr. Wotton served...

  Articles 2008-07-07

• Endo and Penwest File Lawsuit Against Actavis Relating to Opana(R) ER

  Endo Pharmaceuticals Inc.,a subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), andPenwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that they havefiled a lawsuit against Actavis South Atlantic LLC in the United StatesDistrict Court for the District of New Jersey in connection with Actavis'sAbbreviated New Drug Application ANDA for OPANA® ER...

  Articles 2008-03-28

• Endo and Penwest Receive Paragraph IV Certification Notice From Actavis for OPANA(R) ER

  Endo PharmaceuticalsHoldings Inc. (NASDAQ: ENDP) and Penwest Pharmaceuticals Co. (NASDAQ: PPCO)announced today that on February 14, 2008, they received a notice fromActavis South Atlantic LLC advising of the filing by Actavis of anAbbreviated New Drug Application ANDA containing a Paragraph IVcertification under 21 U.S.C. Section 355j for oxymorphone hydrochlorideextended-release tablets...

  Articles 2008-02-15

• Introduces Penwest Pharmaceuticals to our Bluechips Radar.

  M2 PRESSWIRE-5 February 2008-IST Market Review: Introduces Penwest Pharmaceuticals to our Bluechips RadarC1994-2008 M2 COMMUNICATIONS LTD RDATE:05022008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole...

  Articles 2008-02-05

• Endo and Penwest File Lawsuit Against Impax Laboratories Relating to OPANA(R) ER

  Endo Pharmaceuticals Inc.,a subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), andPenwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that they havefiled a lawsuit against IMPAX Laboratories, Inc. in the United StatesDistrict Court for the District of Delaware in connection with IMPAX'sAbbreviated New Drug Application ANDA for OPANA® ER oxymorphone HClextended-release...

  Articles 2008-01-25

• CoNCERT Pharmaceuticals Names W. James O'Shea and Daniel Grau to Product Advisory Board

  LEXINGTON, Mass. -- CoNCERT Pharmaceuticals Inc., the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today the addition of two new members to its Product Advisory Board PAB. The PAB, now comprising seven members, was established at CoNCERT's inception as a...

  Articles 2008-01-03

• Endo and Penwest Receive New Paragraph IV Certification Notice From IMPAX for OPANA(R) ER

  Endo PharmaceuticalsHoldings Inc. (NASDAQ: ENDP) and Penwest Pharmaceuticals Co. (NASDAQ: PPCO)announced today that on December 14, 2007, they received a notice fromIMPAX Laboratories, Inc. advising of the FDA's acceptance for substantivereview, as of November 23, 2007, of IMPAX's Abbreviated New DrugApplication ANDA containing a new Paragraph IV certification under...

  Articles 2007-12-17

• IMPAX Comments on Lawsuit Related to Generic Version of Opana® ER

  HAYWARD, Calif. -- IMPAX Laboratories, Inc. (OTC:IPXL) today confirmed that Endo Pharmaceuticals Holdings Inc. and Penwest Pharmaceuticals Co. have filed a lawsuit against the Company in the United States District Court for the District of Delaware alleging patent infringement related to IMPAX's filing of an Abbreviated New Drug Application ANDA...

  Articles 2007-11-19

• Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER

  Endo Pharmaceuticals Inc., asubsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), andPenwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that they havefiled a lawsuit against IMPAX Laboratories, Inc. in the United StatesDistrict Court for the District of Delaware in connection with IMPAX'sAbbreviated New Drug Application ANDA for OPANA® ER oxymorphone HClextended-release...

  Articles 2007-11-15

• Market Alerts: ISNY! October 4, 2007

  Stock Market Alerts' performance stock listincludes: Internet Song of the Year, Inc. (PINKSHEETS: ISNY), PenwestPharmaceuticals Co. (NASDAQ: PPCO), NutriSystem (NASDAQ: NTRI), LDK SolarCo., Ltd. (NYSE: LDK). Having just released breaking news, Internet Song of the Year, Inc.(PINKSHEETS: ISNY) should have investors closely monitoring the stock thismorning. This morning, the company...

  Articles 2007-10-04